Crescent Grove Advisors’s Micron Technology MU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.34M Sell
3,763
-259
-6% -$194K 0.36% 63
2026
Q1
$1.36M Sell
4,022
-88
-2% -$34.5K 0.13% 117
2025
Q4
$1.17M Buy
4,110
+400
+11% +$91.8K 0.11% 117
2025
Q3
$621K Buy
3,710
+5
+0.1% +$640 0.06% 155
2025
Q2
$457K Buy
3,705
+20
+0.5% +$1.87K 0.04% 169
2025
Q1
$321K Hold
3,685
– – 0.03% 204
2024
Q4
$311K Hold
3,685
– – 0.03% 210
2024
Q3
$382K Hold
3,685
– – 0.04% 193
2024
Q2
$485K Sell
3,685
-7,023
-66% -$885K 0.05% 167
2024
Q1
$1.26M Hold
10,708
– – 0.13% 103
2023
Q4
$915K Sell
10,708
-4,000
-27% -$297K 0.1% 123
2023
Q3
$1M Hold
14,708
– – 0.12% 112
2023
Q2
$928K Hold
14,708
– – 0.1% 117
2023
Q1
$887K Sell
14,708
-585
-4% -$34.3K 0.1% 116
2022
Q4
$766K Buy
15,293
+585
+4% +$32K 0.08% 139
2022
Q3
$737K Hold
14,708
– – 0.09% 125
2022
Q2
$813K Sell
14,708
-2,565
-15% -$174K 0.09% 122
2022
Q1
$1.34M Sell
17,273
-86
-0.5% -$7.33K 0.13% 87
2021
Q4
$1.62M Buy
+17,359
New +$1.36M 0.15% 76

Other funds holding MU

Crescent Grove Advisors's MU Position: Q2 2026 in Review

Crescent Grove Advisors reduced its Micron Technology (MU) stake by 6.4% in Q2 2026, selling an estimated $194K and leaving 3,763 shares worth $4.34M. The position accounts for 0.36% of the portfolio, ranked #63.

Crescent Grove Advisors first reported a position in MU in Q4 2021 and has held it in 19 quarters since. 3,913 funds tracked by Wall St. Rank hold MU as of Q2 2026.

  • Crescent Grove Advisors held 3,763 shares of Micron Technology worth $4.34M as of Q2 2026.
  • Crescent Grove Advisors sold 259 Micron Technology shares in Q2 2026, an estimated $194K.
  • Micron Technology made up 0.36% of Crescent Grove Advisors's portfolio in Q2 2026, its #63 holding.
  • Crescent Grove Advisors first reported a position in Micron Technology in Q4 2021 and has held it in 19 quarters since.
  • 3,913 funds tracked by Wall St. Rank held Micron Technology as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.